Cellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Test Type (Single Test Panels v/s Multi Test Panels), By Sample (Blood, Saliva, Urine, Others), By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others), By Region
Published Date: November - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Healthcare | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationCellular Health Screening Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F, Segmented by Test Type (Single Test Panels v/s Multi Test Panels), By Sample (Blood, Saliva, Urine, Others), By Site of Collection (Home, Hospitals & Clinics, Diagnostic Laboratories, Others), By Region
The Global Cellular Health Screening Market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to the growing sedentary lifestyle and an aging population, consequently resulting in diseases like diabetes and obesity. Additionally, growing adoption of telomere performance programs for maintaining a healthy life such as maintaining a healthy weight with healthy eating, exercise regularly along with the growing importance of healthy life expectancy and the growing adoption of direct to customer approach is expected to create significant growth during the forecasted period. . Additionally, growing geriatric population across the globe, which is susceptible to different kinds of diseases and obesity, is further expected to increase the demand for cellular health screening, thereby fuelling the market growth through 2028. Besides, growing number of cancer patients due to bad food habit across the globe, along with different chronic diseases, is increasing the demand for cellular health screening during the forecast period.
This year, an estimated 66,470 people (48,520 men and 17,950 women) will be diagnosed with head and neck cancer in the United States.
Growing Prevalence of Chronic Diseases is Driving the Market’s Growth
Around 46% of all diseases worldwide and 60% of the 56.5 million deaths in 2001 were due to chronic conditions.
Increasing Geriatric Population Propelling the Market Growth
In 2020, an estimated 1,806,590 new cases of cancer was diagnosed in the United States and 606,520 people was died from the disease.
The technology analyzes blood samples to identify potential health risks and provides tailored recommendations for diet, exercise, and supplements to optimize overall health. BiomeFx is a cellular health screening technology that analyzes an individual's gut microbiome to identify potential health risks. The technology provides recommendations for dietary changes and supplements to optimize gut health and overall well-being. Liquid biopsy is a non-invasive method of cellular health screening that involves analyzing blood samples for the presence of cancer cells and other abnormal cells. This technology has the potential to revolutionize cancer screening, allowing for earlier detection and more effective treatment. Telemedicine is a rapidly growing field that allows for remote healthcare consultations and screenings. This technology has the potential to increase access to cellular health screening for individuals who may not have easy access to healthcare facilities. Wearable technology such as smartwatches and fitness trackers can provide valuable data on an individual's physical activity, heart rate, and other health metrics. This data can be integrated into cellular health screening analyses, providing a more complete picture of an individual's overall health. Artificial intelligence (AI) is being increasingly used in cellular health screening to analyze large amounts of data and identify patterns and correlations that may not be apparent to human analysts. AI can help to improve the accuracy and efficiency of cellular health screening, leading to more effective disease prevention and management.
Recent Development
- Lab Corp announced in April 2022 that it has launched a home collection service for various diagnostic and screening test offerings of the company.
- In September 2020, Genova Diagnostics partnered with Rocky Mountain Analytical, a subsidiary of LifeLabs. The partnership allowed greater accessibility of Genova’s tests for Canadian patients and clinics.
Market Segmentation
The global cellular health screening market can be segmented by test type, by sample, by site of collection and by region. Based on test type, the market can be divided into Single Test Panels v/s Multi Test Panels. Based on sample, the market can be segmented into Blood, Saliva, Urine, Others. Based on site of collection, the market can be differentiated Home, Hospitals & Clinics, Diagnostic Laboratories, Others. Regionally, North America dominated the market among Asia Pacific, Europe, Middle East & Africa, and South America. Among the different countries, United States dominated the global cellular health screening market on account of growing demand for maintaining healthy life expectancy, along with growing adoption of new technology in the country.
Market Players
Telomere Diagnostics, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, SpectraCell Laboratories, Inc., Cell Science Systems Corporation, Immundiagnostik AG, Repeat Diagnostics, Inc., OPKO Health, Inc., Genova Diagnostics, Inc., Titanovo, Inc. are some of the leading players operating in the Global Cellular Health Screening Market.
| Attribute | Details |
| Base Year | 2022 |
| Historic Data | 2018 – 2021 |
| Estimated Year | 2023 |
| Forecast Period | 2024 – 2028 |
| Quantitative Units | Revenue in USD Million, and CAGR for 2018-2022 and 2023-2028 |
| Report coverage | Revenue forecast, company share, competitive landscape, growth factors, and trends |
| Segments covered | · By Test Type · By Sample · By Site Of Collection · By Region |
| Regional scope | North America; Europe; Asia Pacific; South America; Middle East & Africa |
| Country scope | United States; Canada; Mexico; France; Germany; United Kingdom; Italy; Spain; China; India; Japan; South Korea; Australia; Brazil; Argentina; Colombia; South Africa; Saudi Arabia; UAE |
| Key companies profiled | Telomere Diagnostics, Inc., Quest Diagnostics, Inc., Laboratory Corporation of America Holdings, SpectraCell Laboratories, Inc., Cell Science Systems Corporation, Immundiagnostik AG, Repeat Diagnostics, Inc., OPKO Health, Inc., Genova Diagnostics, Inc., Titanovo, Inc. |
| Customization scope | 10% free report customization with purchase. Addition or alteration to country, regional & segment scope. |
| Pricing and purchase options | Avail customized purchase options to meet your exact research needs. Explore purchase options |
| Delivery Format | PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy